These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 25901828)

  • 1. Potent potassium.
    Öhrström L
    Nat Chem; 2015 May; 7(5):464. PubMed ID: 25901828
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
    Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of nitrosamines from waste water by potassium ferrate oxidation.
    Bartzatt R; Nagel D
    Arch Environ Health; 1991; 46(5):313-5. PubMed ID: 1953040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the inhibitory effects of nifedipine and nimodipine on mechanical responses of isolated rat coronary small arteries.
    Nyborg NC; Mikkelsen EO
    J Cardiovasc Pharmacol; 1987 May; 9(5):519-24. PubMed ID: 2439831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AY-31,906, a novel high ceiling diuretic: characterization of its relative potassium-sparing actions in rats and dogs.
    Ackerman DM; Brady MM; MacLean AG; Smith TM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1113-9. PubMed ID: 2600806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid phase synthesis, NMR structure determination of α-KTx3.8, its in silico docking to Kv1.x potassium channels, and electrophysiological analysis provide insights into toxin-channel selectivity.
    Kohl B; Rothenberg I; Ali SA; Alam M; Seebohm G; Kalbacher H; Voelter W; Stoll R
    Toxicon; 2015 Jul; 101():70-8. PubMed ID: 25953725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the biological activity of dendrotoxin-I, a potent potassium channel blocker.
    Katoh E; Nishio H; Inui T; Nishiuchi Y; Kimura T; Sakakibara S; Yamazaki T
    Biopolymers; 2000 Jul; 54(1):44-57. PubMed ID: 10799980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
    Lagrutta A; Wang J; Fermini B; Salata JJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flunarizine is a highly potent inhibitor of cardiac hERG potassium current.
    Trepakova ES; Dech SJ; Salata JJ
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):211-20. PubMed ID: 16495758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium-stimulated calcium uptake in astrocytes and its potent inhibition by nimodipine.
    Hertz L; Bender AS; Woodbury DM; White HS
    J Neurosci Res; 1989 Feb; 22(2):209-15. PubMed ID: 2709443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties.
    Peigneur S; Billen B; Derua R; Waelkens E; Debaveye S; Béress L; Tytgat J
    Biochem Pharmacol; 2011 Jul; 82(1):81-90. PubMed ID: 21477583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effect.
    Sato N; Ando M; Ishikawa S; Jitsuoka M; Nagai K; Takahashi H; Sakuraba A; Tsuge H; Kitazawa H; Iwaasa H; Mashiko S; Gomori A; Moriya R; Fujino N; Ohe T; Ishihara A; Kanatani A; Fukami T
    J Med Chem; 2009 May; 52(10):3385-96. PubMed ID: 19459652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-diaminopyridine. A potent new potassium channel blocker.
    Kirsch GE; Narahashi T
    Biophys J; 1978 Jun; 22(3):507-12. PubMed ID: 667299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of voltage-gated and calcium-activated potassium channels.
    Kaczorowski GJ; Garcia ML
    Curr Opin Chem Biol; 1999 Aug; 3(4):448-58. PubMed ID: 10419851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sodium-potassium-activated adenosine 5'-triphosphatase and ion transport by adriamycin.
    Gosálvez M; van Rossum GD; Blanco MF
    Cancer Res; 1979 Jan; 39(1):257-61. PubMed ID: 216483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kv1.3 potassium channel-blocking toxin Ctri9577, novel gating modifier of Kv4.3 potassium channel from the scorpion toxin family.
    Xie C; Li T; Xu L; Yu C; Cao Z; Li W; Wu Y
    Biochem Biophys Res Commun; 2014 Feb; 444(3):406-10. PubMed ID: 24472546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
    Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
    Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
    Yang IC; Scherz MW; Bahinski A; Bennett PB; Murray KT
    J Pharmacol Exp Ther; 2000 Sep; 294(3):955-62. PubMed ID: 10945846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the vasoconstrictor responses to potassium depolarization and norepinephrine and their antagonism by differing classes of vasodilators in the perfused rat hindquarters.
    Sybertz EJ; Vander Vliet G; Baum T
    J Pharmacol Exp Ther; 1983 Dec; 227(3):621-6. PubMed ID: 6317841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction.
    Matsui H; Shimosawa T; Uetake Y; Wang H; Ogura S; Kaneko T; Liu J; Ando K; Fujita T
    Hypertension; 2006 Aug; 48(2):225-31. PubMed ID: 16818802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.